Urine testing is relatively cheap and easy to do. Urine testing can be used to check for blood in the urine, to check for infection (by detecting the presence of white blood cells or protein) and can show up other systemic problems such as liver problems (by showing abnormal bilirubin levels). Urine testing can also detect ketones in the urine. Ketones are by-products of metabolism which form in the presence of severe high blood glucose. The presence of ketones in the urine therefore indicates that patients' blood glucose level is likely to be very high and that they may have ketoacidosis, which is a potentially life-threatening complication of diabetes and needs urgent treatment. Early signs of ketoacidosis include passing large amounts of urine, severe thirst, feeling nauseous, tiredness, abdominal pain and shortness of breath. Advanced signs include rapid breathing, rapid heartbeat, vomiting, dizziness, confusion and drowsiness; patients may even lose consciousness. Urgently refer patients with any of the above signs.
Although not as accurate as a blood glucose test, urine testing can be used as a screening tool in patients known to have diabetes. Even in patients with no ketoacidosis, high glucose levels may be an indication that their diabetes is poorly controlled. These patients can be referred for counselling, patient education, and -as soon as possible -for an eye examination to look for signs of diabetic retinopathy. Urine testing can also be used to detect glucose in the urine in undiagnosed patients; they will need to be referred for further tests and perhaps a diagnosis of diabetes. All patients with diabetes should have an eye examination once a year. fill the container three-quarters full, then place the lid on the top.
• If the patient is unable to perform this themselves, they will need assistance.
• Wash your hands and put gloves on prior to taking the container from the patient.
• Remove the lid and dip the reagent strip into the urine, completely immersing the strip in the urine (Figure 1 ). Remove immediately and tap on the side of the urine container to shake off the last drops.
• Hold the strip at an angle to allow any remaining urine to drain away.
• Wait the required time (as outlined on the reagent strip container) before determining the results by comparison with the colour chart on the side of the reagent strip container (Figure 2 ). Be careful not to touch anything, whether the side of the reagent strip container or any other surface.
• Dispose of the urine in an appropriate manner.
• Dispose of the contaminated equipment (gloves, reagent strip and urine container, if disposable) as your policy for clinical waste dictates.
• Remove gloves and wash hands.
• Record your readings in the patient's care notes.
• If readings are abnormal for the patient, pass the information on to someone who is responsible for the patient's care.
CLINICAL SKILLS FOR OPHTHALMOLOGY
Urine testing for diabetic analysis www.iapb.standardlist.org • The laser device should only be used by a qualified physician.
• Do not use any laser device if you think it is not functioning properly.
• Do not bend or stretch the fibre cords.
When storing or packing, roll them into large circles to prevent damaging the fibres.
• All maintenance and calibrations on laser devices should only be conducted by factory-trained technicians.
• When conducting laser treatments, place a sign on the door to the treatment area to alert people that laser therapy is taking place and to not enter (Figure 2 ).
• Laser beams reflected from reflective surfaces can harm your eyes, the patient's eyes, or others' eyes. Any mirror or metal object that reflects the laser beam can constitute a reflection hazard. Be sure to remove all reflection hazards near the laser. Use nonreflecting instruments whenever possible. Be careful not to direct the laser beam at unintended objects.
• All personnel in the treatment area should wear the proper laser safety glasses designed to filter the specific wavelengths and power of the laser being used. The safety eyewear needed is based on the Maximum Permissible Exposure (MPE), Nominal Ocular Hazard Area (NOHA), and Nominal Ocular Hazard Distance (NOHD) for each of the delivery devices used with the laser system, as well as the configuration of the treatment room. For additional information, refer to the laser device's user manual and well as international laser standards and guidelines.
• Safety filters (Figure 3 ) protect the physician from back-scattered laser light. Integral eye safety filters should be permanently installed in every slit lamp and laser indirect ophthalmoscope. For endophotocoagulation or for operating microscope use, a separate discrete eye safety filter assembly must be installed into each viewing path of the operating microscope. All eye safety filters have an optical density (OD) at the laser wavelength sufficient to permit long-term viewing of diffuse laser light. 
